# US 2014/0154333 A1 · Medicinal compositions containing honey

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0154333 A1
- Document ID: US20140154333A1
- Status: Published application
- Kind: A1
- Application number: 14/065,250
- Filed: 2013-10-28
- Published: 2014-06-05
- Earliest claimed: 2006-05-31
- Assignees: Medihoney Pty Ltd.
- Applicants: Medihoney Pty Ltd.
- Inventors: Anthony Peter Moloney
- Web page: https://patentgrep.com/patent/US20140154333A1

## CPC

- A61K 35/644: Beeswax; Propolis; Royal jelly; Honey
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 27/02: Ophthalmic agents
- A61P 27/16: Otologicals
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present invention relates to medicinal compositions containing a honey having non peroxide antibacterial activity and wherein the composition comprises from about 19% to about 80% water by weight. The use of these compositions in the treatment of eye, respiratory and ear conditions is also disclosed.

## Claims

### Claim at position 1

-22. (canceled)

### Claim 23

A method of treating a microbial based ophthalmic condition in a subject, the method comprising administering to the subject a therapeutically effective amount of a medicinal composition comprising a filtered honey having non-peroxide antibacterial activity,
wherein the honey is substantially derived from a Leptospermum species;
wherein the honey has been filtered to exclude particles with a diameter of greater than about 25 microns;
wherein the filtered honey does not undergo yeast fermentation normally associated with honey at moisture contents greater than 19% water by weight;
wherein the composition comprises at least 19% and less than 80% water by weight and has a water activity of about 0.63 to about 0.85; and
wherein the ophthalmic condition is selected from the group consisting of chronic corneal oedema associated with Fuchs dystrophy, post operative bullous keratopathy, neurotrophic keratitis, recurrent corneal erosion syndrome corneal abrasions/recurrent erosions, corneal ulcers, corneal oedema, chronic blepharitis, chronic meibomitis with marginal keratitis, tear deficient dry eye, contact lens dry eye, chronic post surgery dry eye, tear deficiency-non autoimmune (non-Sjogrens NSTD), tear deficiency-autoimmune (Sjogren's syndrome SSTD), meibomian gland disease (MGD), tear deficiency and meibomian gland disease, graft vs host disease, blepharitis, bacterial conjunctivitis, marginal conjunctivitis, keratitis, Fuchs dystrophy, canaliculitis (infection associated with using plugs), contact lens epitheliopathy, mucocele and staphylococcus blepharitis.

### Claim 24 (depends on 23)

The method of claim 23, wherein the composition comprises between 19% and less than 27% water by weight.

### Claim 25 (depends on 23)

The method of claim 23, wherein the composition comprises about 25% water by weight.

### Claim 26 (depends on 23)

The method of claim 23, wherein the composition comprises about 30% water by weight.

### Claim 27 (depends on 23)

The method of claim 23, wherein the microbial based ophthalmic condition is a bacterial infection.

### Claim 28 (depends on 23)

The method of claim 23, further comprising treatment with another pharmaceutical agent for treating an ophthalmic, respiratory or ear condition.

### Claim 29 (depends on 23)

The method of claim 23, wherein the honey is substantially derived from Leptospermum scoparium.

### Claim 30 (depends on 23)

The method of claim 23, wherein the composition further comprises at least one tonicity adjusting agent.

### Claim 31 (depends on 23)

The method of claim 23, wherein the composition further comprises one or more compounds selected from the group consisting of: a surfactant, a viscosity adjusting agent, a buffering agent, a preservative agent, and a combination thereof.

### Claim 32 (depends on 23)

The method of claim 23, wherein said administering comprises one or more of the administration forms selected from the group consisting of: washing, lavage, irrigation, flushing, rinsing, drops, and a spray.

### Claim 33 (depends on 23)

The method of claim 23, wherein said honey has been filtered to exclude particles with a diameter of greater than about 10 microns.

### Claim 34 (depends on 23)

The method of claim 23, wherein said honey has been filtered to exclude particles with a diameter of greater than about 5 microns.

### Claim 35

A method of treating a microbial infection in a subject, the method comprising administering to the subject a therapeutically effective amount of a medicinal composition comprising a filtered honey having non-peroxide antibacterial activity,
wherein the honey is substantially derived from a Leptospermum species;
wherein the honey has been filtered to exclude particles with a diameter of greater than about 25 microns;
wherein the filtered honey does not undergo yeast fermentation normally associated with honey at moisture contents greater than 19% water by weight;
wherein the composition comprises at least 19% and less than 80% water by weight and has a water activity of about 0.63 to about 0.85; and
wherein the microbial infection is caused by a microbial species selected from the group consisting of: Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Acinetobacter baumanni, Pseudomonas aeruginosa, Enterococcus faecalis, and Enterococcus faecium.

### Claim 36 (depends on 35)

The method of claim 35, wherein the composition comprises about 30% water by weight.

### Claim 37

A method of treating a microbial based respiratory condition in a subject, the method comprising administering to the subject a therapeutically effective amount of a medicinal composition comprising a filtered honey having non-peroxide antibacterial activity,
wherein the honey is substantially derived from a Leptospermum species;
wherein the honey does not comprise particles with a diameter of greater than about 25 microns;
wherein the filtered honey does not undergo yeast fermentation normally associated with honey at moisture contents greater than 19% water by weight;
wherein the composition comprises at least 19% and less than 80% water by weight and has a water activity of about 0.63 to about 0.85; and
wherein the respiratory condition is a bacterial based condition selected from the group consisting of a lung or bronchopulmonary infection, an infection associated with cystic fibrosis, tuberculosis or AIDS, pneumonia, acute bacterial bronchitis, common cold, sinusitis, acute rhinitis, atrophic rhinitis, pharyngitis, tonsillitis, laryngitis and a bacterial infection of the nasal cavity.

### Claim 38 (depends on 37)

The method of claim 37, wherein the composition comprises about 30% water by weight.

### Claim 39

A method of treating a microbial based ear condition in a subject, the method comprising administering to the subject a therapeutically effective amount of a medicinal composition comprising a filtered honey having non-peroxide antibacterial activity,
wherein the honey is substantially derived from a Leptospermum species;
wherein the honey does not comprise particles with a diameter of greater than about 25 microns;
wherein the filtered honey does not undergo yeast fermentation normally associated with honey at moisture contents greater than 19% water by weight; and
wherein the composition comprises at least 19% and less than 30% water by weight and has a water activity of about 0.63 to about 0.85; and
wherein the ear condition is bacterial based external otitis, acute or chronic otitis media.

### Claim 40 (depends on 39)

The method of claim 39, wherein the composition comprises about 30% water by weight.
